Eli Lilly (LLY) is a publicly traded Healthcare sector company. As of November 17, 2026, LLY trades at $1,412.07 with a market cap of $1.29T and a P/E ratio of 38.84. LLY moved -1.37% today. Year to date, LLY is +32.64%; over the trailing twelve months it is +39.76%. Its 52-week range spans $623.78 to $1,474.42. Analyst consensus is strong buy with an average price target of $1,513.32. Rallies surfaces LLY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks LLY insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $1,412.07 |
| Market Cap | $1.29T |
| P/E Ratio | 38.84 |
| EPS | $29.84 |
| Dividend Yield | 1.73% |
| 52-Week High | $1,474.42 |
| 52-Week Low | $623.78 |
| Volume | 247.76K |
| Avg Volume | 0 |
| Revenue (TTM) | $79.67B |
| Net Income | $26.71B |
| Gross Margin | 83.40% |
24 analysts cover LLY: 0 strong buy, 22 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $1,513.32.